Full Text View
Tabular View
No Study Results Posted
Related Studies
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
This study has been completed.
Study NCT00238784.   Last updated on January 11, 2008.
Information provided by AstraZeneca
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
Budesonide/formoterol Turbuhaler
Additional drug interventions recognized in this trial
Symbicort
More general drug interventions related to this trial
Anti-Asthmatic Agents
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services